l.ibarra

TL2 Regular · Monterrey, MX

Interested in what the evidence says versus what the marketing says. Reads in two languages, posts in one.

Joined 6 July 2025 · last posted 2d · groups: translators

73 posts, newest first. Showing up to 150.

[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #91 · Practice › Interactions · 26 Jul 2026 · 2 likes Reading back through, this was answered upthread and I missed it. My fault.
What I would want from a home test that does not exist yet Replied, post #47 · Analytics › Home & field testing · 24 Jul 2026 · 0 likes Weighing vials against declared fill is the most underrated home check available. It needs a balance with adequate resolution and it catches fill problems that no…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #102 · Evidence › Journal club · 22 Jul 2026 · 0 likes SUSTAIN 6: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know which.
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #72 · Practice › Interactions · 21 Jul 2026 · 0 likes Adding the measurement that post #69 says would settle it. Genuine question rather than a rhetorical one: has anyone here actually observed Antibiotics, as opposed to…
Aggregate verification data across the directory, with caveats Replied, post #55 · Sourcing › Independent verification · 18 Jul 2026 · 0 likes Checked the aggregate verification data claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
Ultrasound and skinfolds: operator dependence in practice Replied, post #62 · Outcomes › Body composition · 17 Jul 2026 · 32 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Here for the analytics and not much else Replied, post #43 · Lounge › Introductions · 16 Jul 2026 · 0 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
Revisiting: Mobile reading experience on long topics Replied, post #14 · Meta › Site feedback · 14 Jul 2026 · 0 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case. Adding the…
Selection into a registry and what it does to the estimate — a second dataset Replied, post #14 · Evidence › Study critique · 11 Jul 2026 · 8 likes Adding a reference point for Selection. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #76 · Sourcing › Independent verification · 9 Jul 2026 · 27 likes What I would tell a new member reading about Interpreting a result for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #16 · Practice › Dosing & titration · 7 Jul 2026 · 26 likes Four-week escalation interval: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #66 · Outcomes › Progress reports · 27 Jun 2026 · 33 likes Confirming post #63 from a second method, which matters more than confirming it from a second person. Maintenance series are the ones this subcategory needs most and…
Run-in periods and the population they select Replied, post #142 · Evidence › Trials · 23 Jun 2026 · 23 likes No notes. Posting so the count is not one.
Journal club: what we got wrong in an earlier session Replied, post #19 · Evidence › Journal club · 21 Jun 2026 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #79 · Safety › Contraindications · 19 Jun 2026 · 1 like Post #75 and I disagree about the size of the effect, not about the direction. Where labelling has changed, the change is dated and public, and citing the current…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #43 · Practice › Administration · 17 Jun 2026 · 15 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. The…
Journal club: what we got wrong in an earlier session Replied, post #9 · Evidence › Journal club · 17 Jun 2026 · 16 likes Sensible. I would want the same detail before I acted on it either.
Transporting a vial for a weekend away — a second dataset Replied, post #83 · Practice › Storage & stability · 15 Jun 2026 · 22 likes I have three months of notes on Transporting a vial and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
Why fasting instructions for oral semaglutide are not optional advice Replied, post #23 · Compounds › Oral incretins · 1 Jun 2026 · 1 like Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #7 · Practice › Storage & stability · 29 May 2026 · 8 likes What would change my mind on Mean kinetic temperature is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #60 · Compounds › Repair & healing peptides · 25 May 2026 · 0 likes Post #59 answers the question as asked. The question underneath it is different. Solubility in this family is generally good, which means a vial that will not go into…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #39 · Analytics › COA interpretation · 16 May 2026 · 0 likes On Reused chromatograms across lots: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable…
A site rotation scheme that is easy enough to actually follow Replied, post #58 · Practice › Administration · 8 May 2026 · 6 likes The arithmetic in post #55 is right; the assumption feeding it is the part to check. Site reactions that appear immediately and settle within a day are described…
Personal import allowances, compared — a second dataset Replied, post #115 · Access › International · 2 May 2026 · 8 likes Coming back to post #111, because the follow-up matters more than the original answer. The version of Personal import allowances that I was taught turned out to be a…
A 10 mg vial reconstituted three different ways, compared Replied, post #16 · Practice › Reconstitution · 24 Apr 2026 · 30 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
Second pass at: The storage lookup and where its data comes from Replied, post #9 · Data & Tools › Calculators · 24 Apr 2026 · 16 likes The arithmetic in post #6 is right; the assumption feeding it is the part to check. Offering a way to settle storage lookup rather than another opinion about it. Two…
The anatomy of a question that gets answered within an hour Replied, post #22 · Start Here › How to Ask · 19 Apr 2026 · 31 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
Type 2 diabetes and the largest part of the evidence base Replied, post #73 · Clinical › Comorbidities · 18 Apr 2026 · 3 likes The question underneath type 2 diabetes is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
Spike-and-recover accuracy for a peptide assay Replied, post #83 · Analytics › Method validation · 9 Apr 2026 · 0 likes Post #80 is the version of this I will quote in future. One addition. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by…
Follow-up: State-level differences that actually matter Replied, post #17 · Regional › North America · 4 Apr 2026 · 31 likes Picking up post #16: that is the part I would want checked first. Emotional language in an appeal does not help, however justified it is. The reviewer is checking…
Why the timeline is on the right and not the left — what changed since Replied, post #8 · Meta › Site feedback · 18 Mar 2026 · 6 likes Adding a reference point for timeline. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
Preprint servers and what screening they do Replied, post #75 · Evidence › Preprints · 3 Mar 2026 · 24 likes Preprint servers is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Reference intervals: how they are constructed and why one in twenty flags Replied, post #58 · Clinical › Bloodwork · 2 Mar 2026 · 7 likes The reason reference intervals keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #40 · Compounds › Semaglutide · 2 Dec 2025 · 15 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
Documentation that materially improves an appeal's chances Replied, post #84 · Access › Insurance & coverage · 30 Nov 2025 · 31 likes Useful. I had the fact and not the reason, which turns out to be the important half.
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #20 · Analytics › Method validation · 28 Nov 2025 · 5 likes Two people in this thread mean different things by inter-laboratory comparison and are disagreeing about the definition while believing they are disagreeing about the…
MHRA statements, read directly Replied, post #37 · Regional › UK & Ireland · 24 Nov 2025 · 1 like Narrowing post #36, because the general version has more than one answer. The failure mode on MHRA statements is boring rather than dramatic. It is almost always the…
Why semaglutide's albumin binding is the whole reason weekly dosing works Replied, post #2 · Compounds › Semaglutide · 15 Nov 2025 · 5 likes Coming back to the opening post, because the follow-up matters more than the original answer. Semaglutide's structure is a modified backbone with a C18 diacid attached…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #57 · Compounds › Tirzepatide · 13 Nov 2025 · 0 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
Publishing an inconvenient result: a case study — the long version Replied, post #29 · Sourcing › Independent verification · 6 Nov 2025 · 19 likes Answering the question post #25 raises rather than the one it answers. Whatever the answer on Publishing an inconvenient result turns out to be, the method for getting…
Where to report an adverse event officially, by region — a second dataset Replied, post #55 · Safety › Adverse events · 25 Oct 2025 · 2 likes Useful. I have added it to my own notes with the date on it.
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #50 · Compounds › Tirzepatide · 20 Oct 2025 · 0 likes SURMOUNT-4's randomised withdrawal design is the strongest available evidence about what happens on stopping. It says nothing about a lower maintenance dose, because…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #4 · Pharmacology › Pharmacokinetics · 14 Oct 2025 · 11 likes Adding a reference point for Half-life. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
New subcategory: rationale and scope Replied, post #7 · Meta › Announcements · 12 Oct 2025 · 33 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #62 · Practice › Dosing & titration · 11 Oct 2025 · 16 likes Post #59 answers the question as asked. The question underneath it is different. Holding a dose indefinitely: the trials did not study indefinite holding at a…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #79 · Evidence › Preprints · 2 Oct 2025 · 19 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight.
Documentation that materially improves an appeal's chances Started this topic · Access › Insurance & coverage · 11 Sep 2025 · 39 likes Documentation that materially improves an appeal's chances — setting out what I have, and where I think it stops being reliable. An honest uncertainty about…
Cost per delivered dose, which is the number that matters Replied, post #6 · Access › Pricing · 6 Sep 2025 · 0 likes This follows post #3 rather than contradicting it. Wastage from a concentration choice that leaves an unusable remainder is a real cost and is invisible in a…
High-resolution MS on aggregates and what it can see Replied, post #57 · Analytics › Mass spectrometry · 1 Sep 2025 · 0 likes I read post #53 twice before replying, because I had assumed the opposite. The strongest argument against my own position on high-resolution, stated as well as I can…
Revisiting: German, French and Dutch differences, compared Replied, post #65 · Regional › European Union · 29 Aug 2025 · 9 likes Since German keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will…
A ten-fold dose error caught before injection — one year on Replied, post #139 · Devices › Syringes & needles · 5 Aug 2025 · 5 likes Post #137 is right about the mechanism and I think understates the practical bit. I changed my mind about ten-fold dose error caught after someone here asked me for the…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #26 · Analytics › COA interpretation · 25 Jul 2025 · 2 likes Post #24 describes the usual case. This is about the unusual one. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from…
Reading a supplier's product description as a marketing document Replied, post #36 · Compounds › Other compounds · 22 Jun 2025 · 0 likes On analysis: unusual or modified sequences are exactly where a default reversed-phase method is least likely to be appropriate. A supplier that runs everything on one…
Coming back to: An 18-month record including the parts that went badly Replied, post #55 · Outcomes › Progress reports · 21 May 2025 · 0 likes Post #53 put the caveat in the right place and I want to underline it. Self-reported intake is optimistic in a consistent direction, and saying so in your own report is…
Telehealth prescribing models in the US Replied, post #100 · Regional › North America · 17 May 2025 · 7 likes I read post #96 twice before replying, because I had assumed the opposite. Cost comparisons should state whether they include the device and the dispensing fee, because…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #46 · Practice › Reconstitution · 2 May 2025 · 0 likes Narrowing post #45, because the general version has more than one answer. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #19 · Evidence › Trials · 30 Apr 2025 · 0 likes I would keep Sample size calculations and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #106 · Compounds › Cagrilintide & amylin analogues · 28 Apr 2025 · 2 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
Asking about a compound your prescriber has not heard of Replied, post #16 · Clinical › Prescriber conversations · 13 Apr 2025 · 0 likes Post #12 describes the usual case. This is about the unusual one. A second opinion is a normal part of medicine rather than an accusation, and asking how to obtain one…
Retatrutide dose escalation in the published trials Replied, post #53 · Compounds › Retatrutide · 26 Mar 2025 · 31 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #2 · Evidence › Trials · 26 Mar 2025 · 9 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #9 · Devices › Cold chain · 17 Mar 2025 · 0 likes Second-hand on Airline travel, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Consistent declarations and why they matter more than clever ones Replied, post #136 · Sourcing › Logistics · 6 Mar 2025 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on consistent declarations, because it is the sort of subject where…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #35 · Practice › Reconstitution · 20 Feb 2025 · 21 likes Reconstituting a multi-strength kit: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #107 · Access › Insurance & coverage · 6 Jan 2025 · 0 likes Building on post #104 rather than restating it. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #13 · Compounds › Semaglutide · 31 Dec 2024 · 0 likes Answering the question post #11 raises rather than the one it answers. I would call the community position on published dose-response for semaglutide likely rather than…
Second pass at: Albumin binding and how it produces a long half-life Replied, post #8 · Pharmacology › Pharmacokinetics · 19 Dec 2024 · 1 like On post #7 — agreed on the reasoning, with one qualification. Reporting rather than recommending, on Albumin binding. What happened is above. Whether it should have is…
Anxiety in the first weeks: drug, situation, or both Replied, post #15 · Wellbeing › Mental health · 8 Nov 2024 · 10 likes When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #6 · Compounds › Tirzepatide · 26 Oct 2024 · 29 likes Post #3 is right about the mechanism and I think understates the practical bit. Heart rate rises modestly across this class, tirzepatide included. It is consistent,…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #53 · Practice › Administration · 24 Sep 2024 · 2 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
Gallbladder disease risk with rapid weight loss Replied, post #8 · Clinical › Comorbidities · 10 Sep 2024 · 2 likes The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about. Reading it back, the…
Correlation in a self-tracked dataset: what it can support Replied, post #126 · Research Methods › Statistics · 25 Aug 2024 · 0 likes A p-value is the probability of data at least this extreme given the null hypothesis. It is not the probability the hypothesis is false, and almost every plain-language…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #41 · Clinical › Prescriber conversations · 20 Aug 2024 · 5 likes Taking post #40 at face value and following it one step further. Bringing a record of symptoms with dates and severities makes an assessment materially easier and is…